Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.
Nabatov, Alexey A
Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. [electronic resource] - Journal of virology Jan 2004 - 524-30 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-538X
10.1128/jvi.78.1.524-530.2004 doi
Antibodies, Monoclonal--pharmacology
CD4 Antigens--metabolism
Chemokine CCL5--pharmacology
Chemokine CXCL12
Chemokines, CC--pharmacology
Chemokines, CXC--pharmacology
Disease Progression
HIV Envelope Protein gp120--chemistry
HIV Infections--immunology
HIV-1--drug effects
Humans
Mutation
Neutralization Tests
Peptide Fragments--genetics
Receptors, CCR5--metabolism
Receptors, CXCR4--metabolism
Solubility
Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. [electronic resource] - Journal of virology Jan 2004 - 524-30 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-538X
10.1128/jvi.78.1.524-530.2004 doi
Antibodies, Monoclonal--pharmacology
CD4 Antigens--metabolism
Chemokine CCL5--pharmacology
Chemokine CXCL12
Chemokines, CC--pharmacology
Chemokines, CXC--pharmacology
Disease Progression
HIV Envelope Protein gp120--chemistry
HIV Infections--immunology
HIV-1--drug effects
Humans
Mutation
Neutralization Tests
Peptide Fragments--genetics
Receptors, CCR5--metabolism
Receptors, CXCR4--metabolism
Solubility